ParentVibes

← All research

🧬 Fertility & IVF

IVF Trends India

Fertility treatment adoption, costs, and access across Indian cities

Updated July 7, 2026Verified sources0 verified datasetsMethodology available

Track your pregnancy journey free

Start Pregnancy Tracker

Headline verified figure

Replace with verified source data

Estimate — replace with latest industry/registry figure

Prepared by
ParentVibes Research Team
Data verification
ParentVibes Research Desk
Medical context
Not individual medical advice
Last updated
July 7, 2026
Next review due
October 7, 2026
Jump to section

Source review in progress. Statistics in this report are structural placeholders pending verified sourcing. See each source note and the methodology page before citing this report.

Executive summary

India has seen substantial growth in fertility clinic infrastructure and public conversation around IVF, but reliable, verified national statistics on cycle volumes, success rates, and costs remain fragmented. This report is structured to hold such data once sourced from ICMR's ART registry, published clinical studies, or credible industry reports. What is independently verifiable today: globally, roughly 1 in 6 people of reproductive age experience infertility in their lifetime (WHO, 2025), and India regulated its fertility/surrogacy sector into an altruistic-only framework with the Surrogacy (Regulation) Act 2021 — following a commercial industry that pre-ban estimates placed anywhere from $400 million to over $2 billion a year, a gap that itself reflects the lack of a single authoritative registry. Current IVF cycle volumes, average per-cycle cost, and Tier-2 clinic growth remain unverified and are marked as such below.

Key statistics

IVF cycles performed annually in India

Replace with verified source data

Estimate — replace with latest industry/registry figure

Source required — e.g. ICMR ART registry or industry association report

Infertility prevalence, globally

Official source

~1 in 6 people of reproductive age

Lifetime prevalence worldwide. WHO has not published an India-specific prevalence figure — treat commonly repeated 'India: 10–15% of couples' claims as unverified until traced to a primary source.

WHO, "Infertility" fact sheet, updated 28 November 2025 — retrieved live July 7, 2026

Average cost per IVF cycle (₹)

Replace with verified source data

Varies significantly by city and clinic

Source required — clinic price surveys or ART registry cost data

Couples reporting fertility-related stress or anxiety

Replace with verified source data

Source required — peer-reviewed study or verified survey

ParentVibes users tracking IVF medication schedules via the app

ParentVibes internal data placeholder

ParentVibes internal data placeholder — aggregated, anonymized platform usage

Growth in fertility clinics in Tier-2 Indian cities (YoY)

Replace with verified source data

Source required

Charts & visual data

Lightweight, static charts with source notes and downloadable data.

Illustrative IVF cost range by city tier

Placeholder cost ranges pending verified clinic pricing data.

City tierTypical cost range per cycle (₹)
MetroSource required
Tier-2Source required

Source note: Source required — replace with verified clinic pricing survey

Pre-ban estimates of India's surrogacy industry scale — sources disagree

These describe the commercial surrogacy industry specifically, before its 2015 ban — not current IVF cycle volume. Included to show how widely early estimates diverged, not as settled figures.

EstimateClinicsAnnual industry valueSource
UN-backed study3,000+$400M+Indian Journal of Medical Ethics, 2018
Confederation of Indian Industry"Thousands"$2B+CII estimate
The Guardian (2012)25,000+ children born via surrogacy/year (~half for overseas couples)Desai, The Guardian, 5 June 2012

Source note: Wikipedia, "Surrogacy in India," retrieved live July 7, 2026, citing a UN-backed study (Indian Journal of Medical Ethics, 2018), the Confederation of Indian Industry, and The Guardian (2012). Not independently re-verified against the primary study/report.

Main findings

1

Fertility treatment is expanding beyond metro cities

Clinic openings and patient inquiries suggest growing demand for fertility care in Tier-2 and Tier-3 cities, though this report needs a verified source before quoting a specific growth rate.

Source required

2

Cost remains a major barrier and a major source of stress

IVF cycle costs vary widely by clinic and city, and can require multiple cycles for a live birth. Couples frequently report the financial and emotional toll as their top concern alongside clinical outcomes.

Source required — cite clinic pricing survey or published research

3

Medication and appointment tracking is a consistent pain point

Aggregated ParentVibes IVF-dashboard usage suggests many patients value structured reminders for injections, scans, and appointments during treatment cycles — an organisational, not clinical, need.

ParentVibes internal data placeholder — aggregated, anonymized platform usage

4

India regulated its fertility sector into an altruistic-only framework by 2021 — after a very large commercial industry

India's assisted-reproduction sector has a well-documented regulatory arc: ICMR issued non-binding ART guidelines in 2005, commercial surrogacy was banned nationally in 2015, a Surrogacy (Regulation) Bill was introduced in 2016 and revised in 2019 and 2020, and the Surrogacy (Regulation) Act was enacted in 2021, establishing an altruistic-only, non-commercial framework overseen by National and State Surrogacy Boards. Before the ban, estimates of the industry's scale varied enormously: a UN-backed study put it at 3,000+ clinics and $400 million a year, while the Confederation of Indian Industry estimated over $2 billion a year; a 2012 Guardian report cited more than 25,000 surrogate births annually, roughly half commissioned by overseas couples. The size of that disagreement is itself telling — India's ART sector has historically lacked a single authoritative public registry.

ICMR guidelines (2005) → commercial surrogacy banned (2015) → Surrogacy (Regulation) Act (2021)

Why it matters for parents

Families considering IVF or surrogacy in India today are operating in a meaningfully more regulated environment than a decade ago — altruistic surrogacy only, with formal oversight boards — worth understanding before comparing India to how the sector is sometimes described in older international reporting.

Wikipedia, "Surrogacy in India," retrieved live July 7, 2026, citing a UN-backed study (Indian Journal of Medical Ethics, 2018), the Confederation of Indian Industry, and The Guardian (5 June 2012) — industry-scale estimates are historical (pre-2015 ban) and disputed between sources; the regulatory timeline itself is independently a matter of public legislative record.

What this means for parents

If you're considering IVF, treat any cost or success-rate figures you read online — including in this report until sourced — as a rough starting point for a conversation with a licensed fertility specialist, not a quote or a guarantee.

Regardless of exact statistics, the consistently reported pattern across fertility journeys is that organisation (tracking medications, appointments, and questions) and emotional support meaningfully ease the process — both areas where tools like the ParentVibes IVF dashboard and community are designed to help.

How ParentVibes verified this report

Retrieved live from the World Bank API

Indicator codes recorded for every verified dataset

Source retrieval date stored with each citation

Modelled estimates clearly labelled

NFHS/SRS figures separated until primary document verification

Methodology linked for citation standards

Medical disclaimer retained for parent safety

Read the full ParentVibes methodology and medical disclaimer.

Methodology

Intended primary sources include the Indian Council of Medical Research (ICMR) Assisted Reproductive Technology (ART) registry data, peer-reviewed fertility research, and industry cost surveys, supplemented by aggregated, anonymized ParentVibes IVF-dashboard usage where explicitly labeled. A July 7, 2026 research pass retrieved WHO's global infertility fact sheet live and Wikipedia's "Surrogacy in India" page (itself citing a UN-backed academic study, the Confederation of Indian Industry, and The Guardian) for regulatory-history context. The same pass attempted, and failed, to verify India-specific IVF cycle volumes, average cost, and clinic growth: the ICMR National ART Registry is not a publicly fetchable dataset through the channels tried; industry market-research pages (Grand View Research, IMARC, Mordor Intelligence) timed out repeatedly, likely due to bot protection; and a PMC/PubMed article was blocked by a reCAPTCHA challenge.

Data sources

  • ICMR National ART Registry (where publicly available)
  • Peer-reviewed fertility and reproductive health research
  • Published clinic/industry cost surveys
  • WHO, "Infertility" fact sheet, updated 28 November 2025 — retrieved live July 7, 2026
  • Wikipedia, "Surrogacy in India" (tertiary source, used only for regulatory-history context) — retrieved live July 7, 2026
  • Aggregated, anonymized ParentVibes IVF dashboard usage (no individual user data)

How to read the data badges in this report

  • Official source

    Published by an official body (WHO) and cited directly from that publication, retrieved live.

  • Primary source pending

    Widely reported via a tertiary source (Wikipedia, citing named primary studies/reports) that was not independently re-fetched this session — verify against the underlying study/report before citing externally.

Limitations

  • National ART registry reporting in India has historically been incomplete; figures should be treated as estimates even once sourced.
  • Costs vary enormously by clinic, protocol, and individual case — any average understates real-world range.
  • IVF cycle volumes, average per-cycle cost, and Tier-2 clinic growth remain unverified as of this edition: the ICMR ART Registry, industry market-research reports, and a PMC/PubMed article could all not be accessed during the July 7, 2026 research pass — these stay explicit placeholders, not settled numbers.
  • Pre-2015-ban surrogacy-industry estimates (clinic count, dollar value) vary enormously between the two sources found ($400M+/3,000+ clinics vs. $2B+/'thousands' of clinics) because India's ART sector has historically lacked one authoritative public registry — treat both as directional, not precise, and as historical rather than current.
  • The WHO infertility-prevalence figure (~1 in 6) is global; no India-specific WHO prevalence figure could be verified, and the commonly cited 'India: 10–15% of couples' claim could not be traced to a primary source this session.

Sources & citations

Each card separates the publisher, dataset or report, indicator code, retrieval date and verification status.

  • Source

    ICMR National ART Registry — cite specific report/year once inserted

    Official health source
    Indicator code
    Not applicable
    Retrieval date
    Source review in progress
    Verification status
    Recorded source
    Source review in progress
  • Source

    Source required — clinic pricing survey or peer-reviewed fertility research

    Source required
    Indicator code
    Not applicable
    Retrieval date
    Source review in progress
    Verification status
    Recorded source
    Source review in progress
  • Source

    ParentVibes internal data placeholder — aggregated, anonymized platform insights

    ParentVibes internal
    Indicator code
    Not applicable
    Retrieval date
    Source review in progress
    Verification status
    Recorded source
    Source review in progress
  • World Health Organization

    Infertility — fact sheet (updated 28 November 2025)

    Global fact sheet: ~1 in 6 people of reproductive age experience infertility in their lifetime; WHO issued its first global infertility guideline in November 2025. No India-specific prevalence figure is published here.

    Official health sourceOfficial source
    Indicator code
    Not applicable
    Retrieval date
    July 7, 2026
    Verification status
    Official health source
  • Wikipedia, citing a UN-backed study (Indian Journal of Medical Ethics, 2018), the Confederation of Indian Industry, and The Guardian (2012)

    Surrogacy in India — regulatory history and industry-scale estimates

    Tertiary source; the underlying UN-backed study, CII estimate, and Guardian reporting were not independently re-fetched this session, and the two industry-scale estimates disagree substantially. Figures describe the pre-2015-ban surrogacy industry specifically, not current IVF cycle volume.

    NewsPrimary source pending
    Indicator code
    Not applicable
    Retrieval date
    July 7, 2026
    Verification status
    Primary document review pending

Frequently asked questions

How much does IVF actually cost in India?

Costs vary widely by clinic, city, and treatment protocol. This report does not yet publish a verified figure — always request a detailed, written cost breakdown from your chosen clinic.

Is this report a substitute for advice from a fertility specialist?

No. This is general, population-level information. Fertility treatment decisions should always be made with a licensed specialist based on your individual medical history.

Can ParentVibes help me manage an IVF cycle?

Yes — the ParentVibes IVF dashboard helps track medications, appointments, and cycle phases. It is an organisational tool, not a medical one.

Is surrogacy legal in India?

Commercial surrogacy was banned nationally in 2015. The Surrogacy (Regulation) Act, enacted in 2021, permits only altruistic (non-commercial) surrogacy under formal oversight by National and State Surrogacy Boards.

How common is infertility — in India and globally?

Globally, WHO estimates that about 1 in 6 people of reproductive age experience infertility in their lifetime (fact sheet updated November 2025). WHO has not published an India-specific prevalence figure, and while Indian media commonly cite '10–15% of couples,' we could not trace that number to a primary, citable source — so this report does not repeat it as verified.

Download the full report

Get a print-ready PDF of this report, including every chart, source, and methodology note.

Related reports

This report offers general, population-level information and is not medical advice for any individual. Always consult your doctor for decisions about your own or your child's health. Read our Medical Disclaimer and Research Methodology.